DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA. The preliminary amendment dated February 16, 2023 is entered. Claims 6 and 7 were amended. Claims 1-12 are pending. Specification The title of the invention is not descriptive. The title includes the word “heterocyclic”, but the recited compounds do not necessarily include a heteroaryl or heterocyclic group. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b ) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the appl icant regards as his invention. Claims 1-12 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Independent claim 1 is directed to “A heterocyclic compound” in the preamble. Use of the term “heterocyclic” to describe the compound is unclear, because a heteroaryl group is not necessarily required to be present within the recited Formula 1 compound. Note for instance that the majority of specific Formula 1 compounds in dependent claim 6 do not include a heteroaryl or heterocyclic group. Many compounds are claimed that only include hydrocarbon rings and are absent of any rings containing heteroatoms. Use of the term “ heterocyclic ” that is contrary to the conventional meaning renders the claims vague and indefinite. Recited claims include the terminology and/or all dependent claims depend upon claim 1 and are therefore included in the rejection. Clarification and/or correction are required. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale , or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim s 1-5 and 7-12 are rejected under 35 U.S.C. 102 (a)(1) or 102(a)(2) as being anticipated by Mun et al. (US 10,840,455 B1). Mun et al. discloses compounds for organic electronic elements (see title and abstract). General formula 1 is taught (see top of column 3): . Definitions are discussed at col. 6, line 34 to 64. More specifically, the following example compound P-14 of formula 1 is taught (see bottom of col. 13): . The compound P-14 corresponds to instant formula 1 of claim 1 where instant Ar1 is aryl, Ar2 and Ar3 include terphenyl and substituted fluorene respectively, R1 is a lk yl, R2 is a lk yl, and L2 is direct bond. With respect to claim 2, compound P-14 is considered to correspond to instant Formula 3. With respect to claim 3, compound P-14 is considered to include a group corresponding to instant Formula A-1. Regarding claim 4, groups corresponding to instant R1 and R2 are the same C1 alkyl group in compound P-14. Regarding claim 5, P-14 only includes a group on the benzofluorene core corresponding to Ar1 and accordingly, positions corresponding to instant R3 to R8 are considered to be hydrogen. Regarding claim 7, an example device was made using compound P-14 (see Table 4 at top of col. 65-66, example (6)). With respect to claims 8 to 11, the claims do not require specific other layers be present and the claims only require an organic layer between electrodes containing the compound. Example (6) of Table 4 containing the compound is considered to meet the structural requirements of claims 8 to 11 (see also col. 59, line 1 to col. 60, line 8). With respect to claim 12, multiple functional layers are present in an example device 6 other than the organic layer containing the compound P-14 (see col. 59, line 1 to col. 60, line 8 and Table 4 at col. 65-66). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim s 1-12 are rejected under 35 U.S.C. 103 as being unpatentable over Mun et al. (US 10,840,455 B1). Mun et al. discloses compounds for organic electronic elements (see title and abstract). General formula 1 is taught (see top of column 3): . Definitions are discussed at col. 6, line 34 to 64. The formula encompasses compounds as claimed, but not all possible compounds of formula 1 the same as claimed are shown as an example in Mun et al. The formula s defined within Mun et al. renders obvious compounds as claimed. For instance with respect to at least instant compound 20 of instant claim 6, Mun et al. formula 1 may be specific formula A-1 (top col. 7) where R e is aryl phenyl, R1 and R2 are alkyl, R3 and R4 are alkyl, Ar1 is biphenyl: Instant 20 Mun et al. A-1 . At least a compound the same as instant compound 20 reads upon the independent claim 1 formula, formula 3 of claim 2, formula A-1 of claim 3, groups of claim 4 with R1 and R2 each as C1 alkyl, correspond s to instant R3 to R8 as hydrogen in claim 5, and the compound 20 of claim 6. With respect to device claims 7-12, Mun et al. teaches example device structures using formula 1 compounds (see Table 4 at top of col. 65-66 ). With further respect to claims 8 to 11, the claims do not require specific other layers be present and the claims only require an organic layer between electrodes containing the compound of formula 1 . A layered structure described by Table 4 containing a formula 1 between electrodes is considered to meet the structural requirements of claims 8 to 11 (see also col. 59, line 1 to col. 60, line 8). With respect to claim 12, multiple functional layers are present in the layered devices other than the organic layer containing a formula 1 compound (see col. 59, line 1 to col. 60, line 8 and Table 4 at col. 65-66). Given the teachings of the reference, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have formed compounds and devices including the compounds as described above wherein the resultant compound and devices would also meet the limitations of the instant claims. One would expect to achieve functional compounds for operational devices with a predictable result and a reasonable expectation of success. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: US 9,260,390 B2 discloses monoamine compounds for an organic electroluminescent device (see title and abstract) where adjacent substituents of a fluorene ring (II) of the monoamine formula (I) may bond to form a further ring , which would result in a benzofluorene group (see col. 2, line 32 to col. 3, line 11). The reference is considered relevant to the state of the art. Katritzky, A.R., Denisko, O.V. "heterocyclic compound." Encyclopedia Britannica, February 22, 2025. https://www.britannica.com/science/heterocyclic-compound . An encyclopedia definition of heterocyclic compound is provided and is considered relevant to the claim language used in the instant application. Any inquiry concerning this communication or earlier communications from the examiner should be directed to FILLIN "Examiner name" \* MERGEFORMAT Dawn Garrett whose telephone number is FILLIN "Phone number" \* MERGEFORMAT (571)272-1523 . The examiner can normally be reached FILLIN "Work Schedule?" \* MERGEFORMAT Monday through Thursday (Eastern Time) . If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, FILLIN "SPE Name?" \* MERGEFORMAT Jennifer Boyd can be reached at FILLIN "SPE Phone?" \* MERGEFORMAT 571-272-7783 . The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DAWN L GARRETT/ Primary Examiner, Art Unit 1786